Rockefeller Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $31.4M | Sell |
246,931
-76,433
| -24% | -$9.71M | 0.5% | 55 |
|
|
2017
Q3 | $38M | Sell |
323,364
-8,694
| -3% | -$1.02M | 0.72% | 42 |
|
|
2017
Q2 | $26.5M | Sell |
332,058
-174,165
| -34% | -$13.9M | 0.53% | 50 |
|
|
2017
Q1 | $25.9M | Buy |
506,223
+495,730
| +4,724% | +$25.4M | 0.52% | 49 |
|
|
2016
Q4 | $393K | Buy |
10,493
+8,591
| +452% | +$322K | 0.01% | 271 |
|
|
2016
Q3 | $129K | Sell |
1,902
-3,400
| -64% | -$231K | ﹤0.01% | 330 |
|
|
2016
Q2 | $294K | Hold |
5,302
| – | – | 0.01% | 298 |
|
|
2016
Q1 | $333K | Hold |
5,302
| – | – | 0.01% | 287 |
|
|
2015
Q4 | $499K | Buy |
5,302
+446
| +9% | +$42K | 0.01% | 254 |
|
|
2015
Q3 | $390K | Buy |
+4,856
| New | +$390K | 0.01% | 273 |
|